Validation of PROMIS in Diverse Cancer Populations

描述（由申请人提供）：患者报告的结果（pro）作为合法的生物医学终点已获得越来越多的认可，2004年NIH启动了PROMIS倡议，通过建立和验证物项库来改进结果测量。如果要实现利用病人报告的结果来监测和改善健康的“承诺”，就必须确保PROMIS工具适用于在专业卫生保健机构之外接受护理的不同人群，并且在心理计量学上是等效的。鉴于种族/民族、年龄和社会阶层群体之间存在巨大的健康差异，这一点尤其重要。然而，在不同群体之间建立对等措施的研究有限。为了填补这一空白，我们提出了一种三管齐下的方法来评估以白人、西班牙裔、黑人和亚洲成年癌症患者为基础的样本中的PROMIS题库措施。我们专注于癌症，因为它是一种主要的慢性疾病，并且在整个疾病轨迹中存在着重要的经验和结果差异。我们选择了5种癌症（女性乳腺癌，子宫癌和宫颈癌，男性和女性结直肠癌和非霍奇金淋巴瘤），以确保广泛的年龄范围和症状。我们使用基于irt的方法和构建验证来评估在疼痛、抑郁、疲劳、社会功能和身体功能领域使用物项库测量。在我们的第一阶段，我们经验丰富的多学科团队将进行定性研究，以评估PROMIS项目库的概念等效性，主要关注拉丁裔和亚洲癌症患者，因为这些群体的研究很少；我们还将把项目翻译成中文。在我们的下一阶段，我们将进行一项基于人群的研究，使用4个癌症登记处（来自加利福尼亚州(2)，新泽西州，路易斯安那州）随机招募4000名在过去6-9个月内诊断出的患者。我们将采访来自每个种族/民族的1000名患者，这些患者平均分为两个年龄组（21-64岁和65-84岁）。参与者将在最初招募时使用混合模式（邮件和电话）进行调查，6个月后再次进行调查。我们的第三个组成部分是一项探索性临床研究（n=200），以检查PROMIS疲劳测量是否能产生足够精确的化疗前6个月随时间变化的估计，以帮助指导护理管理。我们的研究将提供一套关于跨亚种群的PROMIS测量性能的综合经验数据，表明任何观察到的差异的可能原因。我们的方法通过制定可用于评估意图的影响、为实践提供信息和监测人口健康差距的措施，利用对PROMIS倡议的投资并扩大其范围。

DESCRIPTION (provided by applicant): Patient-reported outcomes (PROs) have gained increasing recognition as legitimate biomedical endpoints and in 2004 NIH launched the PROMIS Initiative to improve outcome measurement by building and validating item banks. If the "promise" of using patient-reported outcomes to monitor and improve health is to be realized, it is essential to ensure that PROMIS tools are appropriate and psychometrically equivalent for diverse populations cared for outside of specialized health care settings. This is especially important given the substantial health disparities across race/ethnic, age and social class groups. However, there has been limited research establishing equivalence of measures across diverse groups. To fill this gap, we propose a 3-pronged approach to evaluate PROMIS item bank measures in a population-based sample of White, Hispanic, Black and Asian adult cancer patients. We focus on cancer since it is a leading chronic disease and one where there are important disparities in experience and outcomes across the disease trajectory. We have selected 5 cancers (female breast, uterine and cervical cancer, and male and female colorectal cancer and non- Hodgkin's Lymphoma) to ensure a wide age range and symptoms. We use IRT-based methods and construct validation to assess the use of item bank measures for the domains of pain, depression, fatigue, social function, and physical function. In our first phase, our experienced, multidisciplinary team will conduct a qualitative study to assess conceptual equivalence of PROMIS item banks, focusing primarily on Latino and Asian cancer patients since there has been little research in these groups; we will also translate items into Chinese. In our next phase, we will conduct a population based study using 4 cancer registries (from California (2), New Jersey, Louisiana) to randomly recruit 4,000 patients diagnosed in the previous 6-9 months. We will interview 1,000 patients from each race/ethnic group divided evenly among two age groups (ages 21-64, and ages 65-84). Participants will be surveyed using a mixed mode approach (mail and phone) at initial recruitment and again 6 months later. Our third component is an exploratory clinical study (n=200) to examine whether the PROMIS fatigue measures generate sufficiently precise estimates of change over time during the first 6 months of chemotherapy to help guide care management. Our study will provide a comprehensive set of empirical data on PROMIS measurement performance across sub- populations, indicating likely causes of any observed differences. Our approach leverages investments in, and extends the scope of, the PROMIS Initiative by developing measures that can be used to evaluate the impact of intentions, inform practice, and monitor population health disparities.